Literature DB >> 16045546

Hyperproduction of fibrin and inefficacy of antithrombin III and alpha2 macroglobulin in the presence of bacterial porins.

Biagio Di Micco1, Pierpaolo Di Micco, Marilena Lepretti, Paola Stiuso, Giovanna Donnarumma, Maria R Iovene, Rita Capasso, Maria A Tufano.   

Abstract

Bacterial porins enhance the thrombin activity upon chromogen substrate chromozym. Should porin-dependent enhancement of thrombin activity take place also upon fibrinogen in vivo, this might greatly increase the fibrin production which, in turn, might lead to blood vessel obstruction. In this study, we demonstrate fibrin hyperproduction in a simplified coagulative system, consisting of fibrinogen and thrombin-pure molecules, in the presence of bacterial porins. In particular, bacterial porins, in the presence of thrombin, significantly increased the fibrin production compared with thrombin alone. Also, fibrin hyperproduction took place even in the presence of the thrombin inhibitors antithrombin III (AT III) or alpha2 macroglobulin (alpha2M). However, the thrombin-fibrinogen reaction in the presence of AT III or alpha2M did not generate fibrin, unless porins were present. In conclusion, porins not only enhance thrombin activity but also inhibit the antithrombin activity exerted by AT III or alpha2M. We hypothesize that, because of porins activity, fibrin is largely generated due to thrombin hyperactivation. Moreover, further fibrin is produced by thrombin, which is not blocked by two serpins for the presence of porins. These results might be relevant as to the occurrence of disseminated intravascular coagulation in sepsis by gram-negative bacteria, which are known to produce porins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16045546      PMCID: PMC2517434          DOI: 10.1111/j.0959-9673.2005.00430.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  18 in total

1.  Inflammatory effects of Salmonella typhimurium porins.

Authors:  F Galdiero; M A Tufano; M Galdiero; S Masiello; M Di Rosa
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

2.  Evidence for allosteric linkage between exosites 1 and 2 of thrombin.

Authors:  J C Fredenburgh; A R Stafford; J I Weitz
Journal:  J Biol Chem       Date:  1997-10-10       Impact factor: 5.157

3.  Determination of soluble fibrin in plasma by a rapid and quantitative spectrophotometric assay.

Authors:  B Wiman; M Rånby
Journal:  Thromb Haemost       Date:  1986-04-30       Impact factor: 5.249

4.  The action of LPS porins and peptidoglycan fragments on human spermatozoa.

Authors:  F Galdiero; F Gorga; C Bentivoglio; R Mancuso; E Galdiero; M A Tufano
Journal:  Infection       Date:  1988       Impact factor: 3.553

5.  A peptide derivative (1-70 fragment) of protein SV-IV accelerates human blood coagulation in vitro by selective inhibition of the heparin-induced antithrombin III activation process.

Authors:  B Di Micco; P Stiuso; G Colonna; R Porta; M Marchese; M E Schinina; M A Macalello; S Metafora
Journal:  J Pept Res       Date:  1997-02

6.  Sepsis, sepsis syndrome, and the systemic inflammatory response syndrome (SIRS). Gulliver in Laputa.

Authors:  R C Bone
Journal:  JAMA       Date:  1995-01-11       Impact factor: 56.272

Review 7.  The role of unsaturated fatty acids in endotoxin-induced macrophage activation.

Authors:  F U Schade; R Engel; S Härtling; J Holler; D Jakobs
Journal:  Immunobiology       Date:  1993-04       Impact factor: 3.144

8.  Outer-membrane porins from gram-negative bacteria stimulate platelet-activating-factor biosynthesis by cultured human endothelial cells.

Authors:  M A Tufano; L Biancone; F Rossano; C Capasso; A Baroni; A De Martino; E L Iorio; L Silvestro; G Camussi
Journal:  Eur J Biochem       Date:  1993-06-15

9.  Rat protein SV-IV (seminal vesicle protein No. 4) accelerates human blood coagulation in vitro by selective inhibition of antithrombin III.

Authors:  B Di Micco; G Colonna; R Porta; S Metafora
Journal:  Biochem Pharmacol       Date:  1994-07-19       Impact factor: 5.858

Review 10.  Thrombin specificity.

Authors:  M C Guillin; A Bezeaud; M C Bouton; M Jandrot-Perrus
Journal:  Thromb Haemost       Date:  1995-07       Impact factor: 5.249

View more
  1 in total

Review 1.  Clinical review: molecular mechanisms underlying the role of antithrombin in sepsis.

Authors:  Christian J Wiedermann
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.